Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajaybabu V Pobbati

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Theranostics|March 25, 2020
A combat with the YAP/TAZ-TEAD oncoproteins for cancer therapyAjaybabu V Pobbati, Wanjin Hong
Cancer Biology & Therapy|February 6, 2013
Emerging roles of TEAD transcription factors and its coactivators in cancersAjaybabu V Pobbati, Wanjin Hong
Molecules (Basel, Switzerland)|December 23, 2020
Protein-Protein Interaction Disruptors of the YAP/TAZ-TEAD Transcriptional ComplexAjaybabu V Pobbati, Brian P Rubin
Science (New York, N.Y.)|August 5, 2006
N- to C-terminal SNARE complex assembly promotes rapid membrane fusionAjaybabu V Pobbati, Alexander Stein, Dirk Fasshauer
Pharmaceuticals (Basel, Switzerland)|April 28, 2023
Leveraging Hot Spots of TEAD-Coregulator Interactions in the Design of Direct Small Molecule Protein-Protein Interaction Disruptors Targeting Hippo Pathway SignalingBin Zhao, Ajaybabu V Pobbati, Brian P Rubin, et al.
Cancers|June 24, 2022
Unraveling the Biology of Epithelioid Hemangioendothelioma, a TAZ-CAMTA1 Fusion Driven SarcomaCaleb N Seavey, Ajaybabu V Pobbati, Brian P Rubin
Trends in Biochemical Sciences|January 28, 2023
Therapeutic targeting of TEAD transcription factors in cancerAjaybabu V Pobbati, Ramesh Kumar, Brian P Rubin, et al.
The Journal of Biological Chemistry|August 19, 2004
Structural basis for the inhibitory role of tomosyn in exocytosisAjaybabu V Pobbati, Adelia Razeto, Matthias Böddener, et al.
Structure (London, England : 1993)|May 29, 2012
Structural and functional similarity between the Vgll1-TEAD and the YAP-TEAD complexesAjaybabu V Pobbati, Siew Wee Chan, Ian Lee, et al.
Plos One|July 29, 2021
Inhibition of PI3K and MAPK pathways along with KIT inhibitors as a strategy to overcome drug resistance in gastrointestinal stromal tumorsAnu Gupta, Shuang Ma, Kepeng Che, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Theranostics|March 25, 2020
A combat with the YAP/TAZ-TEAD oncoproteins for cancer therapyAjaybabu V Pobbati, Wanjin Hong
Cancer Biology & Therapy|February 6, 2013
Emerging roles of TEAD transcription factors and its coactivators in cancersAjaybabu V Pobbati, Wanjin Hong
Molecules (Basel, Switzerland)|December 23, 2020
Protein-Protein Interaction Disruptors of the YAP/TAZ-TEAD Transcriptional ComplexAjaybabu V Pobbati, Brian P Rubin
Science (New York, N.Y.)|August 5, 2006
N- to C-terminal SNARE complex assembly promotes rapid membrane fusionAjaybabu V Pobbati, Alexander Stein, Dirk Fasshauer
Pharmaceuticals (Basel, Switzerland)|April 28, 2023
Leveraging Hot Spots of TEAD-Coregulator Interactions in the Design of Direct Small Molecule Protein-Protein Interaction Disruptors Targeting Hippo Pathway SignalingBin Zhao, Ajaybabu V Pobbati, Brian P Rubin, et al.
Cancers|June 24, 2022
Unraveling the Biology of Epithelioid Hemangioendothelioma, a TAZ-CAMTA1 Fusion Driven SarcomaCaleb N Seavey, Ajaybabu V Pobbati, Brian P Rubin
Trends in Biochemical Sciences|January 28, 2023
Therapeutic targeting of TEAD transcription factors in cancerAjaybabu V Pobbati, Ramesh Kumar, Brian P Rubin, et al.
The Journal of Biological Chemistry|August 19, 2004
Structural basis for the inhibitory role of tomosyn in exocytosisAjaybabu V Pobbati, Adelia Razeto, Matthias Böddener, et al.
Structure (London, England : 1993)|May 29, 2012
Structural and functional similarity between the Vgll1-TEAD and the YAP-TEAD complexesAjaybabu V Pobbati, Siew Wee Chan, Ian Lee, et al.
Plos One|July 29, 2021
Inhibition of PI3K and MAPK pathways along with KIT inhibitors as a strategy to overcome drug resistance in gastrointestinal stromal tumorsAnu Gupta, Shuang Ma, Kepeng Che, et al.
Pageof 3